🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to look at the efficacy and safety of Irinotec...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2020-02-11
Trial ID
NCT04083235
Treatments Being Tested
This multi-site, Phase 1/2 clinical trial is an open-label study to identif...
Status
Recruiting
Location
Precision NextGen Oncology
Start Date
2023-11-01
Trial ID
NCT06047379
This is a Phase I/II, single-arm, open-label, multi-center study to evaluat...
Status
Recruiting
Location
Beijing Cancer Hospital
Start Date
2026-08-12
Trial ID
NCT07790510
The purpose of this phase I study to determine the optimal dose for the com...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2011-08-23
Trial ID
NCT01383538
Treatments Being Tested
This is a prospective, multicenter, single-arm, open-label study. The main ...
Status
Recruiting
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2023-10-18
Trial ID
NCT06389760
Treatments Being Tested
This open-label, prospective, single-arm, multicenter study will evaluate t...
Status
Completed
Location
Canberra Hospital
Start Date
2012-06-26
Trial ID
NCT01588990
Treatments Being Tested
The purpose of this study is: 1. To determine the proportion of Asian pati...
Status
Unknown
Location
National University Hospital
Start Date
2009-06
Trial ID
NCT00943137
Treatments Being Tested
This study is being done to determine the dose of a chemotherapy drug (irin...
Status
Completed
Location
University of Chicago Comprehensive Cancer Center
Start Date
2012-03-26
Trial ID
NCT01643499
Determine the relapse-free survival of resected pancreatic cancer patients ...
Status
Completed
Location
Abramson Cancer Center of the University of Pennsylvania
Start Date
2013-04
Trial ID
NCT01839799
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and toxicity of irino...
Status
Active Not Recruiting
Location
Blokhin's Russian Cancer Research Center
Start Date
2025-03-01
Trial ID
NCT06967155